Clinical Trials
14 trialsNCT07586709 2026-05-14
In Vivo BCMA/GPRC5D Tandem Dual CAR-T Therapy for Relapsed/Refractory Plasma Cell Neoplasms
Chinese PLA General Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT07519187 2026-04-09
CAR 70-BCMA CAR-T Cells for the Treatment of Relapsed or Refractory Plasma Cell Neoplasms
The General Hospital of Western Theater Command
Phase EARLY_PHASE1 Not yet recruiting
NCT06986434 2026-04-08
CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic Differentiation
Affiliated Hospital to Academy of Military Medical Sciences
Phase EARLY_PHASE1 Not yet recruiting
NCT01269593 2026-01-15
PET Imaging of Cancer Patients Using 124I-PUH71: A Pilot Study
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT04862676 2025-09-10
Repeated HBO Therapy in Myeloma Patients Undergoing High-Dose Therapy and Auto-HCT
University of Rochester
Phase EARLY_PHASE1 Completed
NCT07077330 2025-07-22
CAR19BCMA
Chinese PLA General Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT03591614 2023-08-18
Dendritic Cell DKK1 Vaccine for Monoclonal Gammopathy and Stable or Smoldering Myeloma
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT03371420 2023-04-18
PET Imaging of Subjects Using 124I-PU-AD
Samus Therapeutics, Inc.
Phase EARLY_PHASE1 Terminated
NCT02851056 2022-11-14
Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT)
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Completed
NCT00424242 2021-09-08
Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
Northwestern University
Phase EARLY_PHASE1 Completed
NCT00470093 2018-11-16
Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Terminated
NCT01861340 2018-09-10
Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Completed
NCT01171092 2017-01-11
A Safety Study Looking at the Combination of Velcade and G-CSF in Patients With Myeloma or Lymphoma
University of Kansas Medical Center
Phase EARLY_PHASE1 Completed
NCT01396200 2013-02-26
Cyclophosphamide and Pulse Dexamethasone With Rapamycin or Hydroxychloroquine
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Completed